Breaking News, Collaborations & Alliances

Amgen, Oxford Genome Sciences Sign Onco-Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amgen and Oxford Genome Sciences (UK) have entered into a strategic collaboration to discover, develop and commercialize novel therapeutic antibodies for the treatment of cancer. This collaboration will enable OGS to  strengthen its pipeline of fully human therapeutic antibodies (mAbs) in cancer based on the target discovery capabilities of its unique OGAP database. OGS and Amgen will jointly discover novel antibodies for the treatment of cancer. The companies will generate fully human antibo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters